Sembolic Price in India: Availability, Cost, and How to Get It

Sembolic Price in India: Availability, Cost, and How to Get It

The conversation around new options for weight management and diabetes care is growing, and semaglutide is frequently at the center of it. Sembolic is one of the Indian semaglutide brands launched after the semaglutide patent expired in India on March 20, 2026. If you're in India and curious about Sembolic, you likely have questions about its availability, cost, and how to access it safely. This article provides a clear, practical overview to help you understand the landscape.

Navigating health decisions requires reliable information. Before making any choices about your treatment plan, it's essential to have a conversation with a qualified professional. Consult your healthcare provider before starting any medication.

What is Semaglutide?

Semaglutide belongs to a class of medications known as GLP-1 (glucagon-like peptide-1) receptor agonists. Originally developed to help manage blood sugar levels in adults with type 2 diabetes, it was also found to have a significant impact on weight.

This has led to its approval in many countries for two primary uses:

1. Type 2 Diabetes Management: To improve glycemic control.
2. Chronic Weight Management: For adults with obesity or who are overweight with at least one weight-related comorbidity, such as high blood pressure or high cholesterol.

Semaglutide is sold under different brand names depending on its form and intended use, including Rybelsus (oral tablet), Ozempic (injectable for diabetes), and Wegovy (injectable for weight management).

What is Sembolic?

Sembolic is a semaglutide brand from Torrent Pharmaceuticals. Torrent launched Sembolic, together with a second brand, Semalix, on March 21, 2026, in both oral (tablet) and injectable formulations, as part of its work in metabolic conditions such as type 2 diabetes and obesity. Torrent's launch release does not state the approved indication for each form. Torrent said it was the first company in India to launch a generic oral semaglutide. The approved use, strength and format can differ between the tablet and the injection, so check the pack and your prescription.

Is Semaglutide Available in India?

Yes, semaglutide is officially available in India. As well as Novo Nordisk's brands below, many Indian companies have launched their own semaglutide brands since March 2026, all of which need approval from the Central Drugs Standard Control Organisation (CDSCO), India's national regulatory body.

Oral Semaglutide (Rybelsus)

The oral tablet form of semaglutide, branded as Rybelsus, is widely available in pharmacies across India. It was one of the first forms of semaglutide to be launched in the country. It is prescribed primarily to help manage type 2 diabetes and comes in different strengths (3 mg, 7 mg, and 14 mg).

Injectable Semaglutide (Ozempic)

Ozempic, the weekly injectable form of semaglutide, was launched in India in December 2025. Like Rybelsus, it is marketed in the country for the management of type 2 diabetes. It comes in a pre-filled pen in 0.25 mg, 0.5 mg and 1 mg doses.

Semaglutide for Weight Management (Wegovy)

Wegovy is the brand name for the higher-dose injectable semaglutide specifically studied and approved for chronic weight management. Novo Nordisk launched it in India on June 24, 2025, in five once-weekly strengths from 0.25 mg to 2.4 mg.

How to Get a Prescription for Semaglutide in India

Semaglutide is a Schedule H prescription drug in India, meaning it cannot be legally purchased over the counter. Attempting to buy it without a valid prescription from unverified online sources can be dangerous, as you risk receiving counterfeit or unsafe products.

The proper and safe way to access this medication involves these steps:

1. Consult a Doctor: The first step is to schedule an appointment with a qualified healthcare provider. An endocrinologist or a diabetologist is an ideal specialist, but a general physician with experience in metabolic health can also guide you.

2. Undergo a Medical Evaluation: Your doctor will conduct a thorough evaluation to determine if semaglutide is appropriate for you. This will include reviewing your medical history, discussing your health goals, and likely checking metrics like your Body Mass Index (BMI), blood pressure, blood sugar levels, and other relevant health markers.

3. Receive a Prescription: If your doctor concludes that semaglutide is a suitable part of your treatment plan, they will provide you with a valid prescription specifying the brand, dosage, and form (oral or injectable).

Understanding the Cost of Semaglutide in India

Cost is a significant consideration for many people. The price of semaglutide in India is not fixed and can vary based on several factors.

Factors Influencing the Price

• Brand and Form: The cost of tablets differs from injections, and Indian brands such as Sembolic are generally priced below Novo Nordisk's brands.
• Dosage: Higher doses of the medication typically cost more.
• Pharmacy: Prices can vary between different pharmacy chains, independent chemists, and online platforms. It can be worthwhile to compare prices from a few reputable sources.
• Location: There might be slight price differences between major metropolitan areas and smaller towns.

Typical Price Ranges

At launch in March 2026, Torrent priced injectable Sembolic from ₹3,999 per month. Higher doses and the tablet form may be priced differently. For comparison, Ozempic launched in India in December 2025 at about ₹8,800 to ₹11,175 per month depending on dose, and Novo Nordisk announced price cuts on March 31, 2026. Prices change, so for precise pricing it is always best to check directly with pharmacies.

Does Insurance Cover Semaglutide?

Insurance coverage for semaglutide in India is conditional. If your doctor prescribes it for managing type 2 diabetes, there is a better chance that your health insurance policy may cover a portion of the cost, depending on your plan's terms for prescription medications.

However, coverage for weight management is less common in standard Indian health insurance policies. It is crucial to contact your insurance provider directly to understand what your specific plan covers.

Common Questions About Accessing Semaglutide

Can I buy it from an online pharmacy?

Yes, you can purchase semaglutide from licensed and reputable online pharmacies in India. However, they will require you to upload a valid prescription from a registered medical practitioner before they can dispense the medication.

Do I need a specialist to prescribe it?

While a specialist like an endocrinologist is often best equipped to manage conditions like diabetes and obesity, a qualified MBBS doctor or general physician can also prescribe semaglutide after a proper evaluation.

Are there generic versions available?

Yes. The semaglutide patent expired in India on March 20, 2026, and many Indian companies, including Torrent (Sembolic), have since launched approved generic brands. Buy them only from licensed pharmacies with a prescription, and be cautious of sellers who do not ask for one, as the product's safety and authenticity cannot be guaranteed.

Seek urgent medical help if you develop severe stomach pain that does not go away (it may spread to your back), signs of a serious allergic reaction, or vomiting so much that you cannot keep fluids down. Low blood sugar is more likely if you also take insulin or a sulfonylurea. Semaglutide is not used in pregnancy.

Making an informed decision about your health is the most important step. Semaglutide represents a significant development in metabolic health, but it's one piece of a larger puzzle that includes diet, exercise, and consistent medical guidance.

This medication is not a quick fix, and its suitability can only be determined by a professional who understands your complete health profile. Consult your healthcare provider before starting any medication.

Sources

• Torrent Pharma official semaglutide launch release for Sembolic and Semalix: https://www.torrentpharma.com/docs/Press_Release_a634006544.pdf
• Ozempic India launch and prices (The National, December 12, 2025): https://www.thenationalnews.com/health/2025/12/12/ozempic-india-weight-loss-drug/
• Novo Nordisk India price cut (Business Today, March 31, 2026): https://www.businesstoday.in/amp/industry/pharma/story/novo-further-cuts-semaglutide-prices-as-generics-enter-india-523336-2026-03-31/
• Wegovy India launch (BioSpectrum India, June 2025): https://biospectrumindia.com/news/95/26285/novo-nordisk-announces-launch-of-injectable-semaglutide-for-weight-management-in-india.html
• Central Drugs Standard Control Organisation (CDSCO), Ministry of Health & Family Welfare, Government of India: https://cdsco.gov.in
• World Health Organization (WHO) — Obesity and Overweight: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
• Indian Council of Medical Research (ICMR) — Management of type 2 diabetes: https://www.icmr.gov.in
• Ministry of Health and Family Welfare, Government of India: https://www.mohfw.gov.in